학술논문

Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis
Document Type
Article
Source
In: Biomedicine and Pharmacotherapy. (Biomedicine and Pharmacotherapy, December 2023, 168)
Subject
Language
English
ISSN
19506007
07533322